title: Does fluconazole prevent cryptococcal meningitis in human immunodeficiency virus-infected patients?
authors.forename: C
authors.initials: C
authors.lastname: Pradier
authors.forename: E
authors.initials: E
authors.lastname: Bernard
authors.forename: C
authors.initials: C
authors.lastname: Lubick
authors.forename: M
authors.initials: M
authors.lastname: Toussaint-Gari
authors.forename: Y
authors.initials: Y
authors.lastname: Pinier
authors.forename: J
authors.initials: J
authors.lastname: Durant
authors.forename: V
authors.initials: V
authors.lastname: Mondain
authors.forename: Y
authors.initials: Y
authors.lastname: Le Fichoux
authors.forename: P
authors.initials: P
authors.lastname: Dellamonica
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D015725:Fluconazole / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D016919:Meningitis, Cryptococcal / Q000517:prevention & control*; D012189:Retrospective Studies
chemical_list: D015725:Fluconazole